KHI Monthly Mixer: KHI Spotlight: Endpoints for C3G and What's Next

The Kidney Health Initiative (KHI) invites members to an informal mixer focused on C3 Glomerulopathy (C3G). This mixer highlights the KHI project that analyzed clinical trial endpoints in C3G, aiming to better define meaningful measures of treatment success for this rare kidney disease. The project culminated in the publication of the manuscript, Developing Therapies for C3 Glomerulopathy, which has informed and supported ongoing research efforts in the field.

Looking ahead, this mixer offers an opportunity to discuss what's next for C3G research, regulatory progress, and related initiatives.

Learning Objectives:

1. Understand the KHI C3G Project: Gain insight into the goals, findings, and impact of the KHI project analyzing clinical trial endpoints for C3G.
2. Stay Informed: Remain up to date on therapeutic developments and ongoing research efforts in the C3G space.
3. Build Community: Connect with KHI members working across disciplines to foster stronger collaborations in rare disease research.
4. Discuss Next Steps: Explore how the field is evolving post-drug approval and what's on the horizon, including the upcoming initiatives.

Register Now!